Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (941-950 of 1,873) with videos related to

Pageof 188
Sort By:
European Journal of Heart Failure|December 12, 2018
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetesRasmus Rørth, Pardeep S Jhund, Søren L Kristensen, et al.
European Journal of Heart Failure|September 18, 2020
Sex-based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartanNasrien E Ibrahim, Ileana L Piña, Alexander Camacho, et al.
European Journal of Heart Failure|April 9, 2013
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)John J V McMurray, Milton Packer, Akshay S Desai, et al.
JACC. Heart Failure|September 13, 2020
Associations Between Depressive Symptoms and HFpEF-Related OutcomesAlvin Chandra, Michael A D Alcala, Brian Claggett, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 14, 2016
Cardiovascular Dysfunction and Frailty Among Older Adults in the Community: The ARIC StudyWilson Nadruz, Dalane Kitzman, Beverly Gwen Windham, et al.
Journal of the American College of Cardiology|February 19, 2013
Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery diseaseTorbjørn Omland, Marc A Pfeffer, Scott D Solomon, et al.
European Journal of Heart Failure|November 29, 2019
Left atrial structure and function and the risk of death or heart failure in atrial fibrillationRiccardo M Inciardi, Robert P Giugliano, Brian Claggett, et al.
The American Journal of Cardiology|November 26, 2008
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)Jonathan P Piccini, Patrick M Hranitzky, Rakhi Kilaru, et al.
Journal of the American Geriatrics Society|September 13, 2024
Association of left atrial function with frailty: The Atherosclerosis Risk in Communities (ARIC) studyDaokun Sun, Romil R Parikh, Wendy Wang, et al.
Journal of the American College of Cardiology|March 9, 2019
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF TrialPeder Langeland Myhre, Muthiah Vaduganathan, Brian Claggett, et al.
Pageof 188

Showing results (941-950 of 1,873) with videos related to

Sort By:
Pageof 188
European Journal of Heart Failure|December 12, 2018
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetesRasmus Rørth, Pardeep S Jhund, Søren L Kristensen, et al.
European Journal of Heart Failure|September 18, 2020
Sex-based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartanNasrien E Ibrahim, Ileana L Piña, Alexander Camacho, et al.
European Journal of Heart Failure|April 9, 2013
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)John J V McMurray, Milton Packer, Akshay S Desai, et al.
JACC. Heart Failure|September 13, 2020
Associations Between Depressive Symptoms and HFpEF-Related OutcomesAlvin Chandra, Michael A D Alcala, Brian Claggett, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 14, 2016
Cardiovascular Dysfunction and Frailty Among Older Adults in the Community: The ARIC StudyWilson Nadruz, Dalane Kitzman, Beverly Gwen Windham, et al.
Journal of the American College of Cardiology|February 19, 2013
Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery diseaseTorbjørn Omland, Marc A Pfeffer, Scott D Solomon, et al.
European Journal of Heart Failure|November 29, 2019
Left atrial structure and function and the risk of death or heart failure in atrial fibrillationRiccardo M Inciardi, Robert P Giugliano, Brian Claggett, et al.
The American Journal of Cardiology|November 26, 2008
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)Jonathan P Piccini, Patrick M Hranitzky, Rakhi Kilaru, et al.
Journal of the American Geriatrics Society|September 13, 2024
Association of left atrial function with frailty: The Atherosclerosis Risk in Communities (ARIC) studyDaokun Sun, Romil R Parikh, Wendy Wang, et al.
Journal of the American College of Cardiology|March 9, 2019
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF TrialPeder Langeland Myhre, Muthiah Vaduganathan, Brian Claggett, et al.
Pageof 188